Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003
NCT01099267 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54
Last updated 2019-11-19
Summary
Multi-center, survival data collection in subjects previously enrolled in study NCT00065156 (Celgene Protocol CC-5013-MDS-003).
Conditions
Sponsors & Collaborators
-
Celgene
lead INDUSTRY
Principal Investigators
-
Barry Skikne, MD · Celgene Corporation
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-01
- Primary Completion
- 2010-10-01
- Completion
- 2010-10-01
Countries
- United States
- Germany
Study Locations
More Related Trials
-
Examination of Trends in Multiple Myeloma Trial Patient Experiences
NCT05860179 ·Status: NOT_YET_RECRUITING
-
N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan
NCT02030964 ·Status: COMPLETED ·Phase: PHASE1
-
CC-4047 in Treating Patients With Myelofibrosis
NCT00669578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers
NCT06987708 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire
NCT05817331 ·Status: COMPLETED
-
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
NCT00099047 ·Status: COMPLETED ·Phase: PHASE2
-
Moving Foward With Myeloma (MFM)
NCT07236502 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
MMRF CureCloud Research Initiative
NCT03657251 ·Status: TERMINATED
-
Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT
NCT04685525 ·Status: WITHDRAWN ·Phase: NA
-
Ph II Study of Azacitidine in Myelofibrosis
NCT00569660 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes
NCT00247026 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Inflammatory Cytokines in Symptom Production in Multiple Myeloma
NCT00688168 ·Status: COMPLETED
-
A Randomized, Phase I, Cross-Over Study to Assess the Relative Bioavailability of Single-Dose Cobimetinib (GDC-0973) in Tablet vs. Capsule Formulation
NCT02136524 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides
NCT00002557 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple Myeloma
NCT04521335 ·Status: TERMINATED ·Phase: PHASE1
-
Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997
NCT00899873 ·Status: COMPLETED
-
A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)
NCT06245941 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
NCT00899080 ·Status: COMPLETED
-
Rollover Study From EXG-US-01
NCT05868499 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
NCT06063486 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
NCT06122831 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
NCT00023621 ·Status: COMPLETED ·Phase: PHASE2
-
CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft Recipients
NCT00227045 ·Status: COMPLETED
-
Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer
NCT00551889 ·Status: COMPLETED ·Phase: PHASE1
-
S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women
NCT00088972 ·Status: TERMINATED ·Phase: PHASE2